(London, ON): The Cardiac Arrhythmia Network of Canada (CANet) and its partners are pleased to announce funding for five new strategic research grants (SRG) totaling over $2.8 million with an additional $2.8 million in matching funds.
The Strategic Research Grants will fund research that brings together clinicians, engineers, social scientists, industry, government and patients, in an effort to reduce premature deaths and suffering caused by heart rhythm disturbances (arrhythmias).
“The projects that are receiving funding will help CANet to meet our strategic goals to decrease hospital admissions and improve the quality of life for millions of Canadians with arrhythmias,” said Dr. Anthony Tang, CEO and Scientific Director of CANet. “We are grateful to our partners for providing the matching funds to help advance this important research.”
CANet invited applications for multidisciplinary, multi-sectoral and multi-centered research programs designed to impact the care and/or lives of people living with arrhythmias. After an intensive review process, CANet awarded the following five projects:
Arrhythmias, such as atrial fibrillation, syncope, and other common heart rhythm disturbances affect millions of Canadians resulting in early unexpected deaths and reduced quality of life. Arrhythmias are projected to be the leading cause of death in Canada by 2020.
For more information, please contact:
519-661-2111 x 81353
The Cardiac Arrhythmia Network of Canada (CANet) is a not-for-profit organization dedicated to transforming Canada’s arrhythmia health care system through integrated trans-disciplinary research and development. The network’s strategy is to invent, prove, and implement innovative solutions to enable patients to take ownership and co-manage their arrhythmia health. CANet is funded by the federal government’s Networks of Centres of Excellence (NCE), Canada’s flagship science and technology program.
CANet and Partners Fund Over $5.6 Million for Arrhythmia Research
2017 CANet Round Three SRG Winners